GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conformis Inc (NAS:CFMS) » Definitions » Debt-to-Equity

Conformis (Conformis) Debt-to-Equity : 0.83 (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Conformis Debt-to-Equity?

Conformis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $1.94 Mil. Conformis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $24.65 Mil. Conformis's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $32.03 Mil. Conformis's debt to equity for the quarter that ended in Jun. 2023 was 0.83.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Conformis's Debt-to-Equity or its related term are showing as below:

CFMS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.43   Max: 3.62
Current: 0.83

During the past 10 years, the highest Debt-to-Equity Ratio of Conformis was 3.62. The lowest was 0.00. And the median was 0.43.

CFMS's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs CFMS: 0.83

Conformis Debt-to-Equity Historical Data

The historical data trend for Conformis's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conformis Debt-to-Equity Chart

Conformis Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 1.60 2.71 0.29 0.51

Conformis Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.46 0.51 0.61 0.83

Competitive Comparison of Conformis's Debt-to-Equity

For the Medical Devices subindustry, Conformis's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conformis's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conformis's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Conformis's Debt-to-Equity falls into.



Conformis Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Conformis's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Conformis's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conformis  (NAS:CFMS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Conformis Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Conformis's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Conformis (Conformis) Business Description

Traded in Other Exchanges
N/A
Address
600 Technology Park Drive, Billerica, MA, USA, 01821
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Executives
Christine Desrochers officer: Fmr Interim CFO & Controller 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Gary P Fischetti director 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Mark A Augusti director, officer: FORMER PRESIDENT & CEO 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Denise E Pedulla officer: FORMER CLO & SECRETARY 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Philip W Johnston director C/O CONFORMIS INC, 600, BILLERICA MA 01821
Carrie Bienkowski director C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Robert S Howe officer: CFO & TREASURER C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
J Brent Alldredge officer: CLO & SECRETARY C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Fallon Kenneth P Iii director 5473 FOX HOLLOW DRIVE, NAPLES FL 34101
Erin Henry officer: CORP CONTROLLER & INTERIM PAO C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Frederick W Driscoll officer: INTERIM CFO & INTERIM TREAS
Paul S Weiner officer: Chief Financial Officer C/O CONFORMIS INC, 28 CROSBY DRIVE, BEDFORD MA 01730
Archon Capital Management Llc 10 percent owner 1100 19TH AVENUE EAST, SEATTLE WA 98112
Patricia A Davis officer: CLO & GENERAL COUNSEL C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 02181
Bradley Langdale director C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD MA 01730